The molecular adsorbent recirculating system (MARS®)

Riordan, 2000, Acure liver failure: targeted artificial and hepatocyte-based support of liver regeneration and reversal of multiorgan failure, J Hepatol, 32, 63, 10.1016/S0168-8278(00)80416-X Sen, 2002, Review article: the molecular adsorbents recirculating system (MARS) in liver failure, Aliment Pharmacol Ther, 16, 32, 10.1046/j.1365-2036.16.s5.5.x Sizer, 2003, 973 Stange, 1999, Molecular adsorbent recycling system (MARS): Clinical results of a new membrane-based blood purification system for bioartificial liver support, Artificial Organs, 23, 319, 10.1046/j.1525-1594.1999.06122.x Heim, 2003, 29, 1 Klammt, 2001, Albumin binding capacity (AbiC) is reduced in commercially available human serum albumin preparations with stabilizers, Z Gastrenterol, 39, 24, 10.1055/s-2001-919056 Stange, 1996, A carrier-mediated transport of toxins in a hybrid membrane. Safety barrier between a patients blood and a bioartificial liver, Int J Artif Organs, 19, 677, 10.1177/039139889601901109 Emerson, 1989, The unique features of albumin: a brief review, Crit Care Med, 17, 690, 10.1097/00003246-198907000-00020 Steiner, 2002 McIntyre, 2002, Characterization of treatment dose delivered by albumin dialysis in the treatment of acute renal failure associated with severe hepatic dysfunction, Clin Nephrol, 58, 376, 10.5414/CNP58376 Evenepoel, 2003, Detoxifying capacity and kinetics of the molecular adsorbent recycling system. Contribution of the different inbuilt filters, Blood Purif, 21, 244, 10.1159/000070697 Mitzner, 2000, Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS; results of a prospective, randomised, controlled clinical trial, Liver Transpl, 6, 277, 10.1053/lv.2000.6355 Sorkine, 2001, Role of the molecular adsorbent recycling system (MARS) in the treatment of patients with acute exacerbation of chronic liver failure, Crit Care Med, 29, 1332, 10.1097/00003246-200107000-00006 Heemann, 2002, Albumin dialysis in cirrhosis with superimposed acute liver injury; a prospective, controlled study, Hepatology, 36, 949, 10.1053/jhep.2002.36130 Mullhaupt, 2002, First clinical experience with molecular adsorbents recirculating system (MARS®) in six patients with severe acute on chronic liver failure, Liver, 22, 59, 10.1034/j.1600-0676.2002.00012.x Guo, 2003, Application of molecular adsorbents recirculating system to remove NO and cytokines in severe liver failure patients with multiple organ dysfunction syndrome, Liver Int, 23, 16, 10.1034/j.1478-3231.23.s.3.7.x Schmidt, 2003, Systemic hemodynamic effects of treatment with the molecular adsorbents recirculating system in patients with hyperacute liver failure: a prospective controlled trial, Liver Transpl, 9, 290, 10.1053/jlts.2003.50051 Catlina, 2003, Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure, Liver Int, 23, 39, 10.1034/j.1478-3231.23.s.3.10.x Contreras, 2003, MARS® therapy improves grade IV hepatic encephaloopathy in acute liver failure prior to liver transplantation. The first case experience in Chile, 15 Pares, 2003, Utility of albumin dialysis in the treatment of cholestaic pruritis, 45 Hoeckerstedt, 2003, MARS® treatment in acute liver failure, 25 Huang, 2003, Perioperative application of artificial liver support system in orthotopic liver transplantation, 27 Liu, 2003, Artificial liver support MARS therapy as a bridge to re-transplantation in two cases on long an hepatic duration, 35 Koivusalo, 2003, Experience with albumin dialysis in five patients with severe overdoses of paracetamol, Acta Anaesthesiol Scand, 47, 1145, 10.1034/j.1399-6576.2003.00190.x Faybik, 2003, Extracorporeal albumin dialysis in patients with Amanita phalloides poisoning, Liver Int, 23, 28, 10.1034/j.1478-3231.23.s.3.8.x van de, 2003, MARS treatment in posthepatectomy liver failure, Liver Int, 23, 44, 10.1034/j.1478-3231.23.s.3.2.x Kellersmann, 2002, Application of molecular adsorbents recirculating system® in patients with severe liver failure after hepatic resection or transplantation: initial single-centre experiences, Liver, 56, 10.1034/j.1600-0676.2002.00011.x Hawker, 2003, Hepatic failure, 431 Wyncoll, 2003, Management of acute poisoning, 823 Myburgh, 2003, Severe head injury, 689 O'Grady, 1989, Early indicators of prognosis in fulminant hepatic failure, Gastroenterology, 97, 439, 10.1016/0016-5085(89)90081-4 Boldt, 1994, Continuous hemofiltration and platelet function in critically ill patients, Critical Care Medicine, 22, 1155, 10.1097/00003246-199407000-00018 Boldt, 1994, Platelet function in critically ill patients, Chest, 106, 899, 10.1378/chest.106.3.899